APA (7th ed.) Citation

Lin, S., Wang, Y., Hu, C., Feng, Y., Tang, X., Fu, P., & Miao, J. (2025). Safety and pharmacokinetics of a novel potent GABA analogue crisugabalin in Chinese subjects with various degrees of renal impairment. Wiley. https://doi.org/10.1002/bcp.70310

Chicago Style (17th ed.) Citation

Lin, Shibeilei, Ye Wang, Chao Hu, Yanhuan Feng, Xi Tang, Ping Fu, and Jia Miao. Safety and Pharmacokinetics of a Novel Potent GABA Analogue Crisugabalin in Chinese Subjects with Various Degrees of Renal Impairment. Wiley, 2025. https://doi.org/10.1002/bcp.70310.

MLA (9th ed.) Citation

Lin, Shibeilei, et al. Safety and Pharmacokinetics of a Novel Potent GABA Analogue Crisugabalin in Chinese Subjects with Various Degrees of Renal Impairment. Wiley, 2025. https://doi.org/10.1002/bcp.70310.